These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1317512)

  • 41. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Lambert-Eaton syndrome. Apropos of 2 cases].
    Gilbert P; Lefebvre P; Richard V; Henriet M; Leconte J; Thiriaux J
    Rev Pneumol Clin; 1992; 48(6):275-8. PubMed ID: 1339000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of small cell carcinoma of the lung associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome].
    Seki N; Mitsui J; Hoshino M; Akishiro M; Ugawa Y; Goto J; Tsuji S
    No To Shinkei; 2006 Jan; 58(1):68-73. PubMed ID: 16482925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Paraneoplastic encephalomyelitis and Lambert-Eaton syndrome].
    Pou Serradell A; Fueyo J; Gomez C; Oliveras C; Espadaler JM; Alameda F; Graus F
    Rev Neurol (Paris); 1992; 148(10):605-9. PubMed ID: 1338234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low rate repetitive nerve stimulation in Lambert-Eaton myasthenic syndrome: peculiar characteristics of decremental pattern from a single-centre experience.
    Luigetti M; Modoni A; Lo Monaco M
    Clin Neurophysiol; 2013 Apr; 124(4):825-6. PubMed ID: 23036181
    [No Abstract]   [Full Text] [Related]  

  • 46. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
    Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
    Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lambert-Eaton syndrome or mixed neuromuscular block: diagnostic difficulties].
    Lefebvre P; Mavroudakis N
    Ann Med Interne (Paris); 1995; 146(1):55-8. PubMed ID: 7741401
    [No Abstract]   [Full Text] [Related]  

  • 48. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intermittent myasthenic syndrome: combination of myasthenia gravis and myasthenic syndrome of the Lambert-Eaton type].
    Sanadze AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):93-7. PubMed ID: 1664626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative evaluation of the status of neuromuscular transmission and evoked skin sympathetic potential in myasthenia syndrome of the Eaton-Lambert type in patients with and without bronchogenic carcinoma].
    Bzhilianskiĭ MA; Sanadze AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):21-5. PubMed ID: 2176034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The Eaton-Lambert myasthenic syndrome and subacute cerebellar degeneration of a nonparaneoplastic origin: a review of a case 4 years later].
    Graus F; Basart E; Fernández Ruiz LC
    Med Clin (Barc); 1999 Jan; 112(2):79. PubMed ID: 10065441
    [No Abstract]   [Full Text] [Related]  

  • 53. Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome.
    Oh SJ; Hatanaka Y; Claussen GC; Sher E
    Muscle Nerve; 2007 Feb; 35(2):178-83. PubMed ID: 17058271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
    Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
    Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lambert-Eaton syndrome, an unrecognized treatable pediatric neuromuscular disorder: three patients and literature review.
    Hajjar M; Markowitz J; Darras BT; Kissel JT; Srinivasan J; Jones HR
    Pediatr Neurol; 2014 Jan; 50(1):11-7. PubMed ID: 24138947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tubular aggregates in autoimmune Lambert-Eaton myasthenic syndrome.
    Cordts I; Funk F; Schulz JB; Weis J; Claeys KG
    Neuromuscul Disord; 2016 Dec; 26(12):880-884. PubMed ID: 27816328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-fiber EMG and clinical correlation in Lambert-Eaton myasthenic syndrome.
    Oh SJ; Ohira M
    Muscle Nerve; 2013 May; 47(5):664-7. PubMed ID: 23505075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
    Squier M; Chalk C; Hilton-Jones D; Mills KR; Newsom-Davis J
    Muscle Nerve; 1991 Jul; 14(7):625-32. PubMed ID: 1922168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgery results in complete cure of Lambert-Eaton myasthenic syndrome in a patient with metastatic Merkel cell carcinoma.
    Siau RT; Morris A; Karoo RO
    J Plast Reconstr Aesthet Surg; 2014 Jun; 67(6):e162-4. PubMed ID: 24704152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lambert-Eaton myasthenic syndrome in bronchogenic carcinoma].
    Lobzin VS; Kosachev VD; Sidorova TG; Rudenko DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):91-4. PubMed ID: 2176053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.